Geographic variation in systemic treatment of metastatic pancreatic adenocarcinoma (mPAC) patients in real world across Europe

被引：0
|
作者：
Taieb, J. [1 ]
Carrato, A. [2 ]
AMellbring [3 ]
Prager, G. [4 ]
Melisi, D. [5 ]
Westphalen, B. [6 ]
Macarulla Mercade, T. [7 ,8 ]
D'Esquermes, N. [9 ]
Ferreras, A. [10 ]
De Jong, F. [11 ]
机构：
[1] Paris Descartes Univ, Sorbonne Paris Cite, Hop Europeen Georges Pompidou, Paris, France
[2] Alcala Univ, Hosp Univ Ramon Y Cajal, CIBERONC, IRYCIS, Madrid, Spain
[3] Shire Sweden AB, Kista, Sweden
[4] Med Univ Vienna, Comprehens Canc Ctr Vienna, Dept Med 1, Clin Div Med Oncol, Vienna, Austria
[5] Univ Verona, Med Oncol, Verona, Italy
[6] Klinikum Univ Munchen, Comprehens Canc Ctr Munchen, Munich, Germany
[7] Vall dHebron Univ Hosp, Barcelona, Spain
[8] Vall dHebron Inst Oncol, Barcelona, Spain
[9] Genactis, Chateauneuf, France
[10] Genactis, Antibes, France
[11] Shire Int GmbH, Glattpark Opfikon, Switzerland
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O - 002
引用
收藏
页码：100 / +
页数：2
相关论文
共 50 条
  • [21] Methylated circulating tumor DNA (Met-DNA) as an independent prognostic factor in metastatic pancreatic adenocarcinoma (mPAC) patients.
    Pietrasz, Daniel
    Wang-Renault, Shufang
    Dahan, Laetitia
    Taieb, Julien
    Le Malicot, Karine
    Rinaldi, Yves
    Doat, Solene
    Phelip, Jean-Marc
    Taly, Valerie
    Bachet, Jean-Baptiste
    Laurent-Puig, Pierre
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [22] Real-world patterns of pain medication use among patients with metastatic pancreatic ductal adenocarcinoma (mPDAC)
    Laursen, Ashley Ann
    Surinach, Andy
    Wang, Shu
    Cockrum, Paul
    George, Ben
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28)
  • [23] How to improve metastatic pancreatic ductal adenocarcinoma patients' selection: Between clinical trials and the real-world
    Pretta, Andrea
    Spanu, Dario
    Mariani, Stefano
    Liscia, Nicole
    Ziranu, Pina
    Pusceddu, Valeria
    Puzzoni, Marco
    Massa, Elena
    Scartozzi, Mario
    Lai, Eleonora
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2022, 13 (05): : 417 - 422
  • [24] Comparing real-world evidence among patients with metastatic pancreatic ductal adenocarcinoma treated with liposomal irinotecan
    Koeller, Jim
    Surinach, Andy
    Arikian, Steven R.
    Zivkovic, Marko
    Janeczko, Patrick
    Cockrum, Paul
    Kim, George
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [25] REAL-WORLD TREATMENT PATTERNS IN THE METASTATIC HORMONE-SENSITIVE PROSTATE CANCER SETTING ACROSS EUROPE
    Castro, E.
    Orji, C.
    Ribbands, A.
    Butcher, J.
    Walley, M.
    Li, W.
    Ghate, S.
    VALUE IN HEALTH, 2024, 27 (06) : S231 - S232
  • [26] Palliative treatment of pancreatic adenocarcinoma in a real-world setting.
    Kordes, Maximilian
    Malgerud, Oscar
    Karimi, Masoud
    Frodin, Jan-Erik
    Liljefors, Maria Gustafsson
    Loehr, Matthias
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [27] Characterization of an oligometastatic state in patients with metastatic pancreatic adenocarcinoma undergoing systemic chemotherapy
    de Choudens, Saryleine de Ortiz
    Visotcky, Alexis
    Banerjee, Anjishnu
    Aldakkak, Mohammed
    Tsai, Susan
    Evans, Douglas B.
    Christians, Kathleen K.
    Clarke, Callisia N.
    George, Ben
    Shreenivas, Aditya
    Kamgar, Mandana
    Chakrabarti, Sakti
    Dua, Kulwinder S.
    Khan, Abdul Haq
    Madhavan, Srivats
    Erickson, Beth A.
    Hall, William A.
    CANCER MEDICINE, 2024, 13 (01):
  • [28] Dosing patterns and treatment patterns in real-world patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) who received FOLFIRINOX in the first line
    MacEwan, Joanna P.
    Silver, Michelle
    Cockrum, Paul
    Sanders, Chad
    Kim, George P.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [29] Treatment Patterns in US Patients Receiving First-Line and Second-Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma in the Real World
    King, Gentry
    Ittershagen, Stacie
    He, Luyang
    Shen, Ying
    Li, Frank
    Villacorta, Reginald
    ADVANCES IN THERAPY, 2022, 39 (12) : 5433 - 5452
  • [30] Treatment Patterns in US Patients Receiving First-Line and Second-Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma in the Real World
    Gentry King
    Stacie Ittershagen
    Luyang He
    Ying Shen
    Frank Li
    Reginald Villacorta
    Advances in Therapy, 2022, 39 : 5433 - 5452
12345